keyword
https://read.qxmd.com/read/38539254/trends-in-the-use-of-neuromuscular-blocking-agents-reversal-agents-and-neuromuscular-transmission-monitoring-a-single-centre-retrospective-cohort-study
#1
JOURNAL ARTICLE
Piet Krijtenburg, Arjen de Boer, Lori D Bash, Gert Jan Scheffer, Christiaan Keijzer, Michiel C Warlé
BACKGROUND: Residual neuromuscular blockade (rNMB) remains a persistent and preventable problem, with serious risks. METHODS: Our objective was to describe and assess patterns in the use of neuromuscular blocking agents (NMBAs), neuromuscular transmission (NMT) monitoring, and factors associated with the use of sugammadex. We performed a retrospective, observational cohort study based on electronic medical records in a large teaching hospital in the Netherlands that introduced an integrated NMT monitoring module with automatic recording in 2017...
March 27, 2024: Perioperative Medicine
https://read.qxmd.com/read/38389166/sugammadex-use-outside-of-the-postoperative-setting
#2
JOURNAL ARTICLE
Hayley T Gartner, Megan A Rech
BACKGROUND: Sugammadex rapidly reverses the nondepolarizing neuromuscular blocking agents (NMBAs) rocuronium and vecuronium. The role of sugammadex is not well-defined outside of the postoperative setting. OBJECTIVE: This study aims to describe sugammadex use outside the postoperative setting for the reversal of nondepolarizing NMBAs. METHODS: This was a single-center, retrospective cohort study conducted in patients who received sugammadex outside of the postoperative setting at an academic medical center between June 2016 and November 2022...
February 22, 2024: Annals of Pharmacotherapy
https://read.qxmd.com/read/38219083/global-trends-in-research-related-to-emergence-agitation-from-1978-to-2023-a-bibliometric-analysis
#3
JOURNAL ARTICLE
Xin Li, Yu Sun
PURPOSE: Emergence agitation (EA) is a postoperative behavioral disorder characterized by a lack of connection between consciousness and behavior. Despite its clinical importance and prevalence in the postoperative setting, the research focus and knowledge structure remain to be systematically mapped. Therefore, we conducted a bibliometric analysis from 1978 to 2023 to address this gap. This study aims to excavate research hotspots, map knowledge structure, uncover emerging trends, and provide invaluable insights for guiding future research endeavors...
January 12, 2024: Journal of Perianesthesia Nursing: Official Journal of the American Society of PeriAnesthesia Nurses
https://read.qxmd.com/read/38149896/rocuronium-induced-anaphylaxis-in-the-perioperative-period-a-clinical-review
#4
REVIEW
David E Harris
Rocuronium, a nondepolarizing neuromuscular blocking agent used for muscle relaxation especially during endotracheal intubation, can cause hypersensitivity reactions. This article provides an overview of anaphylactic reactions; risk factors; and the pathophysiology, presentation, diagnosis, treatment, and nursing implications associated with rocuronium-induced anaphylaxis. Life-threatening anaphylaxis can be immunoglobulin E-mediated or non-immunoglobulin E-mediated and usually occurs after the first dose. Anaphylaxis can present with hypotension and bronchospasm; cutaneal symptoms, such as erythema, may not be obvious...
January 2024: AORN Journal
https://read.qxmd.com/read/38112045/emergency-department-usage-of-sugammadex-in-a-large-regional-health-system
#5
JOURNAL ARTICLE
Paul S Jansson, Marc P T Pimentel, Raghu R Seethala
No abstract text is available yet for this article.
December 19, 2023: Academic Emergency Medicine
https://read.qxmd.com/read/37627844/the-impact-of-rocuronium-and-sugammadex-on-length-of-stay-in-patients-undergoing-open-spine-surgery-a-propensity-score-matched-analysis
#6
JOURNAL ARTICLE
En-Bo Wu, Yan-Yi Li, Kuo-Chuan Hung, Amina M Illias, Yung-Fong Tsai, Ya-Ling Yang, Jo-Chi Chin, Shao-Chun Wu
Enhanced Recovery After Surgery (ERAS), an all-encompassing perioperative care approach, has been demonstrated to enhance surgical results, mitigate postoperative issues, and decrease the length of hospital stay (LOS) in diverse surgical specialties. In this retrospective study, our objective was to examine the influence of muscle relaxant selection on LOS and perioperative results in adult patients undergoing open spine surgery. Specifically, we compared 201 patients who received cisatracurium and neostigmine with 201 patients who received rocuronium and sugammadex, after 1:1 propensity score matching...
August 12, 2023: Bioengineering
https://read.qxmd.com/read/37595303/extreme-paralysis-following-rocuronium-administration-in-a-myasthenia-gravis-patient-a-case-report
#7
JOURNAL ARTICLE
Kelsey Billups, Charlotte Collins, Aimee Weber
INTRODUCTION: The use of paralytics during rapid sequence intubation (RSI) in patients with myasthenia gravis (MG) remains a controversial topic in emergency medicine. Due to fewer functional acetylcholine receptors, these patients can be both sensitive and resistant to different types of neuromuscular blocking agents (NMBA). Their atypical sensitivity to non-depolarizing NMBAs such as rocuronium can increase both the duration and depth of paralysis after its use at typical RSI doses...
August 2023: Clinical Practice and Cases in Emergency Medicine
https://read.qxmd.com/read/37588779/safety-of-sugammadex-for-myasthaenia-gravis-patients-undergoing-general-anaesthesia-a-retrospective-database-study
#8
JOURNAL ARTICLE
Isao Nahara, Masato Takeuchi, Hiroshi Yonekura, Chikashi Takeda, Koji Kawakami
BACKGROUND: Using neuromuscular blocking drugs (NMBDs) for patients with myasthaenia gravis remains a challenge in perioperative management. Sugammadex has enabled the safe use of NMBDs. We investigated whether the adverse outcomes, and the treatment used for myasthaenic crises and tracheotomy, are affected by NMBD use in patients with myasthaenia gravis under general anaesthesia. METHODS: Patients with myasthaenia gravis who underwent general anaesthesia were retrieved from the Diagnostic Procedure Combination/Per-Diem Payment systems in Japan between 1 January 2010 and 30 November 2020...
December 2022: BJA Open
https://read.qxmd.com/read/37564851/emergency-use-of-sugammadex-after-failure-of-standard-reversal-drugs-and-postoperative-pulmonary-complications-a-retrospective-cohort-study
#9
JOURNAL ARTICLE
Melanio Bruceta, Preet M Singh, Anthony Bonavia, Zyad J Carr, Kunal Karamchandani
BACKGROUND AND AIMS: The use of sugammadex instead of neostigmine for the reversal of neuromuscular blockade may decrease postoperative pulmonary complications. It is unclear if this finding is applicable to situations where sugammadex is administered after the administration of neostigmine. The objective of this study was to compare the incidence of a composite outcome measure of major postoperative pulmonary complications in patients who received sugammadex as a rescue agent after neostigmine versus those who received sugammadex alone for reversal of neuromuscular blockade...
2023: Journal of Anaesthesiology, Clinical Pharmacology
https://read.qxmd.com/read/37482584/successful-reversal-of-remimazolam-anesthesia-in-a-cannot-intubate-can-ventilate-situation-a-case-report
#10
JOURNAL ARTICLE
Shota Sekimoto, Shuya Kiyama, Shoichi Uezono
BACKGROUND: Compared to other intravenous anesthetics, availability of a specific antagonist flumazenil is a clear advantage of remimazolam. We report a patient who could be rapidly woken up when laryngoscopy and tracheal intubation were unexpectedly difficult. CASE PRESENTATION: A 62-year-old man was scheduled to have resection of a small gingival tumor. Preoperative airway examination was unremarkable except for an omega-shaped epiglottis. Anesthesia was induced with remifentanil/remimazolam infusion and rocuronium...
July 24, 2023: JA Clinical Reports
https://read.qxmd.com/read/37401010/the-effect-of-neuromuscular-blockade-reversal-agents-on-postoperative-pulmonary-complications-in-patients-undergoing-femur-fracture-repair-surgery-a-retrospective-observational-study
#11
JOURNAL ARTICLE
Sung-Ae Cho, Jun-Ho Kim, Choon-Kyu Cho, Tae-Yun Sung
BACKGROUND: Femoral fracture repair surgery under general anesthesia is associated with postoperative pulmonary complications (PPCs). However, information on PPCs caused by residual neuromuscular blockade following perioperative use of neuromuscular blockers is limited. This study aimed to identify the differences in the incidence of PPCs according to the type of neuromuscular blockade reversal agent used in femoral fracture repair surgery, as well as the risk factors for PPCs. METHODS: We retrospectively analyzed the electronic medical records of 604 patients aged >18 years who underwent general anesthesia for femoral fracture repair surgery at a single university hospital between March 2017 and March 2022...
September 2023: Annals of geriatric medicine and research
https://read.qxmd.com/read/37356339/post-intubation-analgesia-and-sedation-following-succinylcholine-vs-rocuronium-in-the-emergency-department
#12
MULTICENTER STUDY
Rick T Carlson, Sneha Shah, Elizabeth Wells, Baruch S Fertel, Matthew J Campbell
BACKGROUND: Succinylcholine and rocuronium are the most commonly utilized neuromuscular blocker agents (NMBAs) for rapid sequence intubation (RSI) in the emergency department (ED). The duration of action of rocuronium is significantly longer (∼30 min) compared to succinylcholine (∼10 min) and previous studies have shown that patients receiving rocuronium are more likely to have longer time to sedation initiation following RSI. Furthermore, patients receiving rocuronium may be more likely to experience awareness with paralysis than those receiving succinylcholine...
September 2023: American Journal of Emergency Medicine
https://read.qxmd.com/read/37345870/good-clinical-research-practice-gcrp-in-pharmacodynamic-studies-of-neuromuscular-blocking-agents-iii-the-2023-geneva-revision
#13
REVIEW
Thomas Fuchs-Buder, Sorin J Brull, Malin Jonsson Fagerlund, Ross J Renew, Guy Cammu, Glenn S Murphy, Michiel Warlé, Matias Vested, Béla Fülesdi, Reka Nemes, Malachy O Columb, Daniela Damian, Peter J Davis, Haijme Iwasaki, Lars I Eriksson
The set of guidelines for good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents was developed following an international consensus conference in Copenhagen in 1996 (Viby-Mogensen et al., Acta Anaesthesiol Scand 1996, 40, 59-74); the guidelines were later revised and updated following the second consensus conference in Stockholm in 2005 (Fuchs-Buder et al., Acta Anaesthesiol Scand 2007, 51, 789-808). In view of new devices and further development of monitoring technologies that emerged since then, (e...
June 22, 2023: Acta Anaesthesiologica Scandinavica
https://read.qxmd.com/read/37345216/evaluation-of-sugammadex-dosing-for-neurological-examination-in-the-emergency-department
#14
JOURNAL ARTICLE
Garrett B Hile, Morgan E Ostinowsky, Nicholas P Sandusky, Gavin T Howington
BACKGROUND: Prolong effects of non-depolarizing neuromuscular blocking agents after rapid sequence intubation may prevent meaningful neurological examination, delaying appropriate diagnosis and neurosurgical intervention. Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium. OBJECTIVE: The objective of this study was to evaluate low- (2 mg/kg) vs standard-dose (4 mg/kg) sugammadex for rocuronium-induced deep neuromuscular blockade reversal in the emergency department (ED) by achieving a post-treatment train-of-four (TOF) of 4 to facilitate neurological examination...
June 21, 2023: Journal of Pharmacy Practice
https://read.qxmd.com/read/37273748/cardiac-arrest-following-sugammadex-administration
#15
A V Pereira, R R Oliveira, C Esteves, M A Coutinho
A 68-year-old man underwent elective surgical repair of an abdominal wall hernia under general anaesthesia. The operation required muscle relaxation, for which we used rocuronium. Following completion of surgery, 180 mg sugammadex was administered intravenously. Shortly afterwards, the patient became severely bradycardic with hypotension, refractory to treatment with ephedrine. This progressed to a pulseless electrical activity cardiac arrest. After 4 min of cardiopulmonary resuscitation, there was return of spontaneous circulation and, following a period of haemodynamic stability in which general anaesthesia was maintained, the patient emerged from anaesthesia without incident...
2023: Anaesthesia reports
https://read.qxmd.com/read/37139057/comparison-of-neostigmine-and-sugammadex-for-hemodynamic-parameters-in-neurointerventional-anesthesia
#16
JOURNAL ARTICLE
Yu-Hsun Tsai, Chun-Yu Chen, Ho-Fai Wong, An-Hsun Chou
INTRODUCTION: Hemodynamic stability is important during neurointerventional procedures. However, ICP or blood pressure may increase due to endotracheal extubation. The aim of this study was to compare the hemodynamic effects of sugammadex and neostigmine with atropine in neurointerventional procedures during emergence from anesthesia. METHODS: Patients undergoing neurointerventional procedures were allocated to the sugammadex group (Group S) and the neostigmine group (Group N)...
2023: Frontiers in Neurology
https://read.qxmd.com/read/37025717/primary-lateral-sclerosis-can-rocuronium-be-an-option
#17
Antonio Palha Ribeiro, Ana Sofia Tomas, Carla Oliveira
Primary lateral sclerosis (PLS) is a neurodegenerative motor neuron disorder that is characterized by corticospinal and corticobulbar dysfunction. In this disease, muscle relaxants in general anesthesia should be used with extreme caution. A 67-year-old woman with a history of PLS was scheduled for laparoscopic gastrostomy due to long-term dysphagia. In the preoperative assessment, she presented a tetrapyramidal syndrome with generalized muscle weakness. A priming dose of 5 mg of rocuronium was administered and the train-of-four (TOF) ratio (T4/T1) after 60 seconds was 70% so induction was followed with fentanyl, propofol, and additional 40 mg of rocuronium...
March 2023: Curēus
https://read.qxmd.com/read/36890961/sugammadex-efficacy-and-dosing-for-rocuronium-reversal-outside-of-perioperative-settings
#18
JOURNAL ARTICLE
Sarah S Harlan, Carolyn D Philpott, Madeline J Foertsch, Sheila C Takieddine, Nicole J Harger Dykes
Background: Sugammadex is approved for postoperative recovery from rocuronium neuromuscular blockade with train-of-four (TOF) guided dosing. Data for non-perioperative sugammadex efficacy and dosing are limited when TOF is not available and reversal is not immediate. Objective: This study evaluated the efficacy, safety, and dose of sugammadex when administered in the emergency department (ED) or intensive care unit (ICU) for delayed rocuronium reversal when TOF guidance was not consistently available. Methods: This single-center, retrospective cohort study included patients over a 6-year period who received sugammadex in the ED or ICU at least 30 minutes after rocuronium administration for rapid sequence intubation (RSI)...
April 2023: Hospital Pharmacy
https://read.qxmd.com/read/36675820/sugammadex-in-emergency-situations
#19
JOURNAL ARTICLE
Cyrus Motamed
Sugammadex may be required or used in multiple emergency situations. Moderate and high doses of this compound can be used inside and outside the operating room setting. In this communication, recent developments in the use of sugammadex for the immediate reversal of rocuronium-induced neuromuscular blockade were assessed. In emergency surgery and other clinical situations necessitating rapid sequence intubation, the tendency to use rocuronium followed by sugammadex instead of succinylcholine has been increasing...
January 15, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/36498526/comparison-of-the-efficacy-and-safety-of-adamgammadex-with-sugammadex-for-reversal-of-rocuronium-induced-neuromuscular-block-results-of-a-phase-ii-clinical-trial
#20
JOURNAL ARTICLE
Yingying Jiang, Yujun Zhang, Zhaoqiong Zhu, Yidan Huang, Dachun Zhou, Jingchen Liu, Chaoyu Li, Xiangdong Chen, Dingxin Kang, Shoushi Wang, Jin Liu, Bin Liu, Wensheng Zhang
This current phase II clinical trial was to compare the effect and safety of adamgammadex, a new cyclodextrin-based selective relaxant binding agent, with sugammadex to reverse rocuronium-induced neuromuscular block. Patients were randomised to receive adamgammadex (4 or 6 mg kg-1 ) or sugammadex (2 mg kg-1 , as a positive control group) at the reappearance of the second twitch (T2 ) in response to TOF stimulation. The standard safety data were collected. The 4 mg kg-1 ( n = 16) and 6 mg kg-1 ( n = 20) adamgammadex- and 2 mg kg-1 ( n = 20) sugammadex-induced recovery time of TOF ratio to 0...
November 25, 2022: Journal of Clinical Medicine
keyword
keyword
158340
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.